Menu
AlphaVet is looking for partners now!
Alpha-Vet, a dynamic member of the Alpha Holding Investment Co. Ltd., stands as a testament to Hungarian entrepreneurship. Established in 1992, this family-owned enterprise has nurtured an unwavering spirit of growth, culminating in the remarkable achievement of a 2022 revenue of 77.7 million EUR and an impressive workforce of over 700 dedicated individuals.
The company’s legacy of resilience continues to be unbroken, with Alpha-Vet emerging as a prominent force in Hungary’s veterinary pharmaceuticals and feed additives distribution landscape. Beyond its market leadership, the company proudly encompasses robust manufacturing capabilities for veterinary pharmaceuticals, feed additives, and even crop and soil conditioning agents.
What truly sets Alpha-Vet apart, however, are its diverse pursuits within its specialized domains. From nurturing the health and well-being of beloved pets through its pet foods and accessories division, to empowering livestock husbandry with cutting-edge equipment and pioneering veterinary instruments, Alpha-Vet embodies versatility and impact across the spectrum of animal care. As the enterprise forges ahead, its legacy of growth, adaptation, and innovation continues to captivate both its industry peers and the entrepreneurial landscape at large.
The Bábolna Pharmaceuticals Manufacturing Plant of Phylaxia Pharmaceuticals Co. Ltd. founded in 1912 has major traditions in the profession. Alpha-Vet started its veterinary pharmaceuticals manufacturing activity by purchasing the assets of that renowned company in 2008.
Alpha-Vet completely renewed and expanded the Bábolna plant and fitted it up with cutting-edge, ‘high-tech’ manufacturing equipment. Improvement of the manufacturing conditions made it possible to continue product development and to further improve the quality of the existing product portfolio.
The plant has EU GMP certification, and is now manufacturing veterinary medicinal products for 18 member states of the European Union and further 7 European countries outside the EU.
The veterinary pharmaceuticals portfolio of Alpha-Vet is made up by products for which there is the greatest demand: in addition to antibiotics and anthelmintics for farm animals, the company manufactures own-developed original products unique in the world for treating skin infections and otitis externa in dogs. By reconstruction, the plant was made suitable for manufacturing premixes, powder mixtures, pelleted products, oral suspensions / solutions and tablets.
The manufacturing capacity of the plant for all types of products is multiple times higher than the Hungarian demand, which ensures the secure supply of products for the export markets and a substantial free capacity for contract manufacturing activity.
Parallel to the development of our manufacturing activity, our research directorate is continuously upgrading our own-developed products portfolio in co-operation with numerous high-ranking European research institutes and universities as partners.
Quality control laboratory with EU GMP certification – a guarantee for fast product release and documents conforming to the EU requirements
We are pleased to offer our wide-ranging registration experience. We have active relations with the competent authorities of 18 EU member states and numerous products with EU registration
Dear Visitor!
It is a closed surface for veterinarians. / It is a closed surface.
If you are not a veterinarian or a pharmacist or an agricultural engineer, you are not authorized to use the site.
Please declare whether you meet the above conditions.
Do you meet the conditions?
